Drugs Made In America Acquisition Corp. - RightsShare · KYG2847J1123 · DMAAR (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Drugs Made In America Acquisition Corp. - Rights
No Price
01.05.2026 20:00
Current Prices from Drugs Made In America Acquisition Corp. - Rights
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
DMAAR
USD
01.05.2026 20:00
0,08 USD
-0,009 USD
-10,50 %
IEX
DMAAR
USD
01.05.2026 19:56
0,08 USD
-0,009 USD
-10,61 %
Share Float & Liquidity
Free Float86,31 %
Shares Float17,61 M
Shares Outstanding20,4 M
Company Profile for Drugs Made In America Acquisition Corp. - Rights Share
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Company Data
NameDrugs Made In America Acquisition Corp. - Rights
CompanyDrugs Made In America Acquisition Corp. Rights
